Pharma Journalist 9027 posts 0 comments

Exacis Biotherapeutics Inc., a development-stage immuno-oncology company working to democratize access to the most advanced and effective cancer treatments, announced several important…
Read More...

A broad coalition of biopharmaceutical and technology leaders announced a new strategic collaboration to promote new and updated standards for advanced therapies. The new collaboration,…
Read More...

Dunad Therapeutics emerges to develop next-generation small molecule therapeutics based on its highly differentiated, tuneable and targeted protein degradation technology. Dunad secured…
Read More...

Pfizer Inc. announced that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the…
Read More...

Sanofi has concluded an agreement to divest an integrated portfolio of its anti-inflammatory drugs to Fidia Farmaceutici, a privately-held company headquartered in Italy. This…
Read More...

In response to ongoing developments throughout the pandemic, NICE has produced numerous rapid COVID-19 guidelines to help healthcare workers respond to the ongoing pandemic. Feedback…
Read More...

Cipla Therapeutics, an affiliate of Cipla Limited and SIGA Technologies, Inc. (SIGA) a commercial-stage pharmaceutical company focused on the health security market announced entering…
Read More...

SemaThera Inc. announced the signing of a multi-year research collaboration and licensing agreement with Roche. The partnership will focus on developing SemaThera’s promising new class…
Read More...

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100™ (aviptadil) in advanced clinical development to treat severe COVID-19 patients, and Acer…
Read More...

BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, announced that it has commenced a Phase 2 clinical trial of…
Read More...